Medical Sciences
Global

Medical Sciences Experts

Shawn Zinnen

Chief Executive Officer
Chemical
MBC Pharma
United States of America

Shawn Zinnen

Biography

Dr. Zinnen graduated with a Ph.D. in Biochemistry and Genetics from Duke University and conducted post-doctoral research at the University of Colorado at Boulder as an NIH Fellow. Dr. Zinnen was previously Associate Director of Biochemistry at Sirna Therapeutics Inc. where he served in various critical roles driving compounds from discovery stage and into human clinical trials and was a key decision maker on the path to four Investigational New Drug filings with the FDA. He invented Sirna Therapeutic Inc.'s (previously Ribozyme Pharmaceuticals Inc.) clinical stage compound Herzyme, an anti-Her-2 targeted ribozyme, that was evaluated in human breast cancer trials. Dr. Zinnen has managed interdisciplinary teams of industry and academic scientists solving pharmacology related problems for diseases ranging from cancer to asthma to macular degeneration. He has authored or coathored 17 papers and 25 patents. 

Research Interest

 Medical 

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Journals
View more
Recommended Conferences
  • Gastroenterology and Hepatology April 24-25, 2019 Budapest | Hungary Theme: Novelties and Current Trends in Gastroenterology and GIT Disorders

    April 24-25, 2019 Budapest, Hungary

  • Hepatobiliary & Pancreatic Disorders September 17-18, 2018 | Philadelphia, Pennsylvania, USA Theme: Innovations in Research & the Treatment of Hepatobiliary & Pancreatic Diseases

    April 24-25, 2019 Budapest, Hungary

  • 32nd World Pediatrics Conference

    October 07-08, 2019 Dublin, Ireland

View more
Relevant Topics